Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 242

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 242
---
 |     |                   | 356,527 |

| 4. | The Company TSR assumes $100 was invested in the Company for the period starting December 31, 2021,                         
 through the end of the listed year. Historical stock performance is not necessarily indicative of future stock performance. |

- 169 -

Relationship Between PEO and Non-PEONEO Compensation Actually Paid and Total Shareholder Return (“TSR”)

The following chart sets forth the relationship between Compensation Actually Paid to our PEOs,
the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company’s cumulative TSR over the three most recently completed fiscal years.

- 170 -

Relationship Between PEO and Non-PEONEO Compensation Actually Paid and Net Income

The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation
Actually Paid to our Non-PEO NEOs, and our net income during the three most recently completed fiscal years. As shown in the chart, net income (loss) for 2024 reflects a preliminary estimate. We are in the
process of finalizing our financial statements for the year ended December 31, 2024, and our actual results remain subject to completion of those financial statements and their audit by our independent registered public accounting firm. This
preliminary estimate are based on information available to management as of the date of this proxy statement and certain related assumptions, which could prove incorrect. Our actual, reported results of operations could differ based on completion of
our year end closing procedures, final adjustments and developments that may arise prior to completion of our annual financial statements, and adjustments arising from the audit by our independent registered public accounting firm. You should
carefully review our audited, consolidated financial statements for the year ended December 31, 2024 when they become available.

- 171 -

DIRECTOR COMPENSATION Director Compensation Policy Our board of directors reviews director compensation periodically to ensure that director compensation remains competitive so that we are able to recruit and retain qualified directors. We have adopted a director compensation policy that provides for certain compensation to our non-employeedirectors (the “Director Compensation Policy”), pursuant to which our non-employeedirectors will receive cash compensation, paid quarterly, as follows:

| • |     | Each non-employee director is entitled to receive an annual cash retainer 
 in the amount of $40,000 per year.                                        |

| • |     | A non-employee chairperson is entitled to